A pharmacotherapy review of the novel,oral antithrombotics |
| |
| Authors: | Kara J Walters PharmD Anna Meador PharmD BCACP John A Galdo PharmD BCPS CGP Katharine Ciarrocca DMD MSEd |
| |
| Affiliation: | 1. PGY-1 Community ResidentSamford University, Birmingham, AL;2. Assistant ProfessorSamford University, Birmingham, AL;3. Assistant Professor, Samford University, Birmingham, AL (Samford) and Clinical InstructorAugusta University College of Dental Medicine, Augusta, GA;4. Assistant Professor, Department of Oral Health & Diagnostic Sciences, Geriatric Dentistry, Oral Medicine/Oral OncologyAugusta University, Augusta, GA |
| |
| Abstract: | Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications. |
| |
| Keywords: | pharmacy anticoagulation medical management surgery |
|
|
